Efficacy, Safety, and Target Engagement of Dazukibart, an IFNβ-Specific Monoclonal Antibody, in Adults With Dermatomyositis: A Multicentre, Double-Blind, Randomised, Placebo-Controlled, Phase 2 Trial
Effect of a Spatial Repellent on Malaria Incidence in an Area of Western Kenya Characterised by High Malaria Transmission, Insecticide Resistance, and Universal Coverage of Insecticide-Treated Nets (Part of the AEGIS Consortium): A Cluster-Randomised, Controlled Trial